Evidence map›Paper›PMID 37967175›Full record

ArticleScience advances2023

Inactivation of the tumor suppressor gene

Jiazhuo He, Zuzana Nascakova, Peter Leary, Giovanni Papa, Tomas Valenta, Konrad Basler, Anne Müller

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Emerging technologies and current challenges in intratumoral microbiota research.Frontiers in cellular and infection microbiology · 2025
    Review
  6. Life science alliance · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 2 countries.

Jiazhuo HeInstitute of Molecular Cancer Research, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-4113-3307
Zuzana NascakovaInstitute of Molecular Cancer Research, University of Zürich, Zürich, Switzerland.ORCID 0000-0003-2035-8061
Peter LearyInstitute of Molecular Cancer Research, University of Zürich, Zürich, Switzerland.ORCID 0000-0003-1430-6185
Giovanni PapaInstitute of Molecular Cancer Research, University of Zürich, Zürich, Switzerland.
Tomas ValentaDepartment of Molecular Life Sciences, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-3043-1835
Konrad BaslerDepartment of Molecular Life Sciences, University of Zürich, Zürich, Switzerland.ORCID 0000-0003-3534-1529
Anne MüllerInstitute of Molecular Cancer Research, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-1368-8276
University of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Helicobacter InfectionsHelicobacter pyloriStomach NeoplasmsAdenomatous Polyposis Coli ProteinAnimalsDNA DamageGenes, Tumor SuppressorHumansMiceReceptors, G-Protein-CoupledStem CellsAdenomatous Polyposis Coli Proteinadenomatous polyposis coli protein, mouseReceptors, G-Protein-Coupled

Identifiers

PMID37967175
PMCPMC10651120
OpenAlexW4388692476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.